3-129559648-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_015103.3(PLXND1):c.5269G>A(p.Asp1757Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,610,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015103.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152020Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000282 AC: 7AN: 248378Hom.: 0 AF XY: 0.0000447 AC XY: 6AN XY: 134118
GnomAD4 exome AF: 0.0000309 AC: 45AN: 1458066Hom.: 0 Cov.: 31 AF XY: 0.0000276 AC XY: 20AN XY: 725176
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152020Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5269G>A (p.D1757N) alteration is located in exon 32 (coding exon 32) of the PLXND1 gene. This alteration results from a G to A substitution at nucleotide position 5269, causing the aspartic acid (D) at amino acid position 1757 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at